BIT
IDIX

BlackRock Institutional Trust’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock Institutional Trust’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,659,731
Closed -$88.2M – 4022
2014
Q2 		$88.2M Buy
3,659,731
+314,215
+9% +$3.28M 0.01% 965
2014
Q1 		$20.2M Buy
3,345,516
+295,700
+10% +$2.06M ﹤0.01% 1953
2013
Q4 		$18.2M Buy
3,049,816
+131,896
+5% +$610K ﹤0.01% 2008
2013
Q3 		$15.1M Buy
2,917,920
+47,900
+2% +$210K ﹤0.01% 2064
2013
Q2 		$10.4M Buy
+2,870,020
New +$11.7M ﹤0.01% 2294

BlackRock Institutional Trust's IDIX Position: Q3 2014 in Review

BlackRock Institutional Trust sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 3,659,731 shares — an estimated $88.2M sold.

BlackRock Institutional Trust first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $88.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock Institutional Trust reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 3,659,731 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $88.2M.
  • BlackRock Institutional Trust first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock Institutional Trust's IDENIX PHARMACEUTICALS INC position peaked at $88.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock Institutional Trust's 13F filing for Q3 2014, filed 29 Oct 2014.